Category: CovidienSyndicate content

Report: Medtronic butts heads with shareholders at annual meeting

August 22, 2014 by Arezu Sarvestani

Some of Medtronic's shareholders aren't pleased about the structure of the $43 billion mega-merger with Covidien, which will stick some long-time backers with significant fees.

Report: Medtronic butts heads with shareholders at annual meeting

FDA OKs return of Covidien's Pipeline embolism device

August 21, 2014 by Brad Perriello

Covidien says it plans to get its recalled Pipeline brain embolism device back on the market immediately, after the FDA approved manufacturing changes aimed at correcting the problem that prompted the recall.

FDA OKs return of Covidien's Pipeline embolism device

Will Medtronic abandon inversion in Covidien deal? | Medtech Wall Street news for the week of August 18, 2014

August 21, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Will Medtronic follow Walgreen and abandon inversion in Covidien deal?; ElectroCore seeks commercial partners for non-invasive headache tech; Allergan-Valeant update: SEC launches Ackman probe, Allergan pays up to $588M for Liris bladder drug, Ackman dangles IPO; Activist investor battles on over ConMed as shareholders vote approaches; Medtronic's Q1 earnings beat The Street on modest sales bump

Will Medtronic follow Walgreen and abandon inversion in Covidien deal?

August 15, 2014 by Brad Perriello

Covidien opens Brazilian training center | MassDevice.com On Call

August 21, 2014 by Arezu Sarvestani

Covidien launches 1st-of-its-kind Center of Innovation in CEO Jose Almeida's home country of Brazil.

MassDevice.com On Call

MASSDEVICE ON CALL — Medtech titan Covidien (NYSE:COV) cut the ribbon on a new training center in Sao Paulo, Brazil, the home country of president & CEO Jose Almeida.

Covidien's atherectomy study finally hits JACC

August 20, 2014 by Arezu Sarvestani

Final results from Covidien's DEFINITIVE LE study, originally closed in 2012, finally appear in the Journal of American College of Cardiology, Cardiovascular Interventions.

Covidien's atherectomy study hits JAMA

It may have taken 2 years but final results from Covidien's (NYSE:COV) DEFINITIVE LE study finally appeared in the Journal of the American College of Cardiology's Cardiovascular Interventions issue.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic CEO Ishrak seeks to reassure employees on MDT-COV deal | The week in medtech M&A

August 20, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Amid political noise, Ishrak seeks to reassure employees on Medtronic-Covidien deal; Will Medtronic follow Walgreen and abandon inversion in Covidien deal?; Medtronic founder Bakken backs Covidien buy; Allergan-Valeant update: SEC launches Ackman probe, Allergan pays up to $588M for Liris bladder drug, Ackman dangles IPO; Allergan CFO Edwards steps down amid hostile Valeant takeover bid

Amid political noise, Ishrak seeks to reassure employees on Medtronic-Covidien deal

August 15, 2014 by Brad Perriello

Medtronic and Covidien reveal their integration teams

August 19, 2014 by Arezu Sarvestani

Medtech titans Medtronic and Covidien name more than 45 people to coordinate the finer points of their merger.

Medtronic and Covidien reveal their integration dream-team

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp